Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,16093,763,1.07 [0.93-1.22],0.354112364063523
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,15498,236,1.08 [0.85-1.37],0.5406972363500724
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,18149,154,1.07 [0.79-1.45],0.6527860475384638
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,11299,852,1.09 [0.95-1.25],0.2343802720413913
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18107,112,1.03 [0.72-1.47],0.886309908471373
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,16172,74,1.21 [0.81-1.78],0.350482696721432
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19284,111,1.03 [0.72-1.48],0.8617366185488069
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19271,76,0.92 [0.58-1.46],0.7132959325184876
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,15768,59,1.35 [0.91-2.01],0.1321157490608902
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,18389,107,1.07 [0.74-1.53],0.7297589869233284
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,18350,68,1.34 [0.91-1.96],0.1365837968393029
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19356,59,1.39 [0.93-2.06],0.1070614345916251
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19397,55,1.14 [0.70-1.84],0.5933140452713652
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19394,52,1.13 [0.69-1.86],0.6341721078977187
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Mycoses,18997,49,0.87 [0.48-1.57],0.6368722384107108
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",18114,365,1.13 [0.93-1.36],0.2207205930433576
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,17868,119,1.01 [0.71-1.44],0.9543371691729736
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18012,263,1.18 [0.95-1.46],0.1349167114082069
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",14013,79,1.04 [0.68-1.57],0.8695208248198024
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",13980,46,0.97 [0.54-1.73],0.9063716051984954
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",14267,333,0.91 [0.73-1.14],0.4252351969757338
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",14275,341,nan [nan-nan],
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",8015,312,1.01 [0.81-1.26],0.95265360475852
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",6400,169,0.91 [0.67-1.25],0.5764242387383585
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",13979,45,1.05 [0.60-1.84],0.8528364416308573
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,16669,612,1.23 [1.06-1.41],0.0048079506993356
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",18100,387,1.21 [1.01-1.44],0.0369220545216007
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,18916,129,1.29 [0.97-1.72],0.0768867912515488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19433,124,1.12 [0.81-1.55],0.4837129904326125
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Rectum,19166,79,0.87 [0.54-1.39],0.5574963396373566
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19436,82,1.41 [1.01-1.95],0.040831331496519
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm: Stomach,19484,58,1.29 [0.84-1.96],0.2439967939770981
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm,19285,240,1.02 [0.80-1.31],0.8668816849309671
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19466,86,1.27 [0.90-1.81],0.1782548125864852
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19468,72,0.88 [0.54-1.44],0.6217830176789776
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19398,49,0.94 [0.53-1.67],0.8419239203919506
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,"Haemangioma, any site",19401,48,0.93 [0.52-1.66],0.7953982097122716
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi,19350,121,0.98 [0.68-1.39],0.8926898204485055
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,19466,51,1.06 [0.63-1.79],0.8372845868482531
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Other benign neoplasms of skin,19360,145,0.84 [0.59-1.19],0.3205014584937556
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Benign neoplasm of breast,10216,39,1.46 [0.92-2.33],0.1096608449815676
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter II Neoplasms,Leiomyoma of uterus,10091,259,1.01 [0.80-1.29],0.9062790266870782
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,18224,161,1.34 [1.05-1.72],0.0198686315903496
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,17791,275,1.22 [0.99-1.50],0.0667569182734788
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,17791,275,1.22 [0.99-1.50],0.0667569182734788
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),15708,439,0.86 [0.70-1.05],0.137618791782739
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,18988,49,0.96 [0.55-1.69],0.8931091498823442
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19206,47,0.57 [0.29-1.14],0.1096951648817344
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,14164,1302,1.18 [1.06-1.31],0.0019658282588363
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,18075,535,1.14 [0.98-1.34],0.0903391459056528
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,17143,111,1.02 [0.72-1.46],0.901283510253263
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18158,137,0.92 [0.65-1.31],0.6579831626252063
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17134,102,1.08 [0.75-1.55],0.6804649122851039
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,17653,621,1.00 [0.85-1.17],0.9926594341968432
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,17634,602,1.00 [0.85-1.18],0.9693569112672408
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,17958,145,0.98 [0.69-1.39],0.8943703739624501
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",17957,144,0.98 [0.69-1.38],0.8920633773277344
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,14011,1149,1.18 [1.06-1.32],0.0030547899153634
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13008,146,1.18 [0.89-1.57],0.2547458134274784
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,13927,1065,1.17 [1.05-1.31],0.0065334401478655
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,12907,45,0.90 [0.49-1.65],0.7369376156801757
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",12934,72,1.27 [0.87-1.86],0.2118635530809579
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Any mental disorder,16023,435,0.88 [0.72-1.07],0.1921496966136386
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",15723,135,1.05 [0.76-1.46],0.7508030972240889
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19175,93,1.10 [0.74-1.63],0.6455135793169243
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19226,68,1.03 [0.64-1.67],0.90235962766526
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,18199,32,1.14 [0.61-2.14],0.6780596311132796
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",19416,32,1.15 [0.60-2.18],0.6792620301513828
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",15620,32,1.14 [0.61-2.12],0.685056335088199
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Alcohol dependence,18204,37,0.95 [0.49-1.82],0.877771365969664
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Smoking dependency,18155,44,1.09 [0.61-1.95],0.7705781365560741
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15617,29,0.48 [0.20-1.19],0.112252799442559
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",15792,204,0.76 [0.56-1.03],0.0736388416516235
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Depression,18286,181,0.80 [0.58-1.10],0.1661370823719418
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Depression or dysthymia,15517,158,0.80 [0.57-1.12],0.1934736087322515
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",15678,90,0.88 [0.57-1.35],0.5570567641658862
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter V Mental and behavioural disorders,Other anxiety disorders,18306,54,0.80 [0.44-1.43],0.4476422821293315
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Neurological diseases,16052,1229,1.02 [0.91-1.15],0.6998063912343675
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14092,85,1.02 [0.67-1.55],0.9377616442485068
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19413,65,1.01 [0.63-1.64],0.9528904552972748
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,18423,384,1.08 [0.89-1.31],0.4330118688968185
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Epilepsy,18146,107,1.08 [0.76-1.55],0.6631585166404668
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Migraine,18089,50,1.33 [0.85-2.07],0.2098113116109915
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19291,45,1.19 [0.72-1.99],0.4979849179501482
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18530,96,1.34 [0.97-1.84],0.071978180343691
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other sleep disorders,18169,130,0.85 [0.59-1.24],0.4039488598581849
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Sleep apnoea,19064,99,0.97 [0.65-1.45],0.8826066617673237
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",18494,580,1.02 [0.87-1.20],0.7950710670231069
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18000,86,0.98 [0.64-1.50],0.9182057092378269
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18264,350,1.00 [0.81-1.23],0.998573682008735
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19182,64,0.70 [0.40-1.24],0.2249565518197166
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Hemiplegia,19166,48,0.73 [0.38-1.39],0.3322157786513067
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Other neurological diseases,19033,95,0.81 [0.52-1.26],0.352654062059336
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",18777,359,1.15 [0.95-1.39],0.1460797354833931
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18634,216,1.14 [0.90-1.46],0.2775927159880207
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18470,52,0.88 [0.50-1.56],0.6582742072787879
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18533,115,1.00 [0.70-1.43],0.998564077571344
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18506,88,1.37 [0.99-1.89],0.0603431455224759
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,14966,207,1.06 [0.81-1.38],0.6815970961659579
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,15267,508,1.05 [0.88-1.24],0.604873305592107
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,18315,235,1.21 [0.96-1.51],0.1048235162485504
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19134,52,1.20 [0.74-1.93],0.4648258512111177
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2156,52,1.34 [0.82-2.19],0.2420481795548872
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",17030,52,1.16 [0.72-1.87],0.5448122378476875
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,18660,113,1.00 [0.69-1.44],0.9908440431184954
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,18605,58,0.83 [0.47-1.45],0.5131838358032008
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",18716,55,0.54 [0.28-1.03],0.0611179593935029
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,18927,81,0.74 [0.45-1.20],0.2184942490190627
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,19411,112,1.31 [0.97-1.76],0.0833114358631679
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,18503,95,1.00 [0.67-1.49],0.9893118480629548
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,12014,3706,0.99 [0.91-1.07],0.7427824421222797
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,18712,79,1.09 [0.72-1.64],0.6791940270194996
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",12769,2583,1.03 [0.95-1.13],0.4622171329337834
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertension,12794,2608,1.04 [0.95-1.13],0.4164206307504335
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10249,63,1.46 [1.00-2.13],0.0517426839533863
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",17094,1457,1.05 [0.95-1.17],0.3329962499792012
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Angina pectoris,16496,859,1.07 [0.94-1.23],0.2979585350199688
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18345,269,1.02 [0.81-1.29],0.8649732700817083
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18630,554,1.04 [0.88-1.23],0.6320014025988202
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19343,112,1.13 [0.80-1.59],0.4808884489346007
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",15988,351,1.07 [0.87-1.32],0.4992333370211018
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,16781,1166,1.02 [0.90-1.15],0.7800155144994959
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,18526,112,1.10 [0.78-1.55],0.5837203412027709
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,18726,233,0.95 [0.73-1.23],0.710319639077154
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18521,107,0.70 [0.45-1.08],0.109930911259439
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18522,108,0.71 [0.46-1.09],0.1161089159256513
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10289,103,0.70 [0.45-1.09],0.1165742749587376
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14476,62,0.94 [0.56-1.57],0.8152511205717068
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Conduction disorders,14550,136,1.37 [1.05-1.78],0.0200123287960856
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,7747,115,0.81 [0.54-1.23],0.3186647564885437
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,8194,562,0.96 [0.80-1.15],0.6598973979207567
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,14492,78,1.10 [0.72-1.66],0.6645041011330369
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,14520,106,1.18 [0.84-1.65],0.3464281464903226
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",18158,245,0.97 [0.75-1.25],0.7979063342657621
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",18442,157,0.74 [0.52-1.05],0.0925797549501712
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",18469,142,0.70 [0.48-1.02],0.0657232171446948
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",18558,124,0.76 [0.51-1.13],0.1737660372185939
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18133,82,1.21 [0.83-1.76],0.3261781358501875
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18196,145,0.97 [0.69-1.35],0.8465238723633265
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18057,136,0.86 [0.60-1.23],0.3947311075571542
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18035,114,0.91 [0.62-1.34],0.6357445863922806
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19242,109,0.96 [0.66-1.40],0.8251258896427806
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Varicose veins,18357,436,1.16 [0.97-1.37],0.0966138084812113
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,Hypotension,18156,91,1.10 [0.75-1.62],0.6157012461691519
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,14434,1809,0.97 [0.87-1.07],0.4898089630886997
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19354,69,1.03 [0.65-1.63],0.8962549715928786
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,17439,223,1.01 [0.78-1.30],0.9429965655432728
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",17411,195,0.92 [0.68-1.22],0.5487066741601829
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,18465,243,1.12 [0.89-1.41],0.3483047516734643
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,18460,238,1.15 [0.91-1.45],0.2292945595188962
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,18865,466,0.85 [0.70-1.04],0.1109807065620221
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,18476,77,0.98 [0.63-1.53],0.9269648971873276
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Nasal polyp,18515,116,0.73 [0.48-1.10],0.1297102141092588
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18692,293,0.90 [0.71-1.14],0.3891133980022521
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,18518,119,1.24 [0.91-1.68],0.1749969651545241
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6257,60,0.45 [0.24-0.86],0.0160969514294949
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,16850,945,1.03 [0.91-1.17],0.6206056457347442
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Early onset COPD,18120,206,0.96 [0.72-1.27],0.7525267492640793
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",18162,248,0.90 [0.69-1.18],0.4506835799252406
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",18162,248,0.90 [0.69-1.18],0.4506835799252406
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",18037,710,1.08 [0.94-1.25],0.2822481953477797
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Asthma,12739,710,1.07 [0.93-1.24],0.3371427009122839
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",12424,710,1.08 [0.94-1.25],0.2811286374788885
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",12732,703,1.08 [0.93-1.25],0.3093316500437642
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19006,113,0.86 [0.58-1.27],0.4377360242062519
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,18088,88,0.76 [0.48-1.21],0.2537132277452654
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",19079,88,0.76 [0.48-1.22],0.2553690121072598
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18082,82,0.86 [0.54-1.36],0.5192837915776239
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Pleural effusion,17157,117,0.86 [0.59-1.27],0.4531915887023273
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,17284,244,0.87 [0.67-1.14],0.3223799802495767
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,18072,113,0.91 [0.62-1.34],0.6340796029903454
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,12592,5333,1.04 [0.97-1.11],0.3263064594589134
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19112,288,0.99 [0.79-1.25],0.9622039765352656
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19488,31,1.19 [0.64-2.22],0.5857236656230305
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Impacted teeth,19489,29,1.13 [0.58-2.21],0.7270928332946972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Dental caries,18907,83,0.94 [0.60-1.46],0.7783514402054328
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,18899,75,1.13 [0.75-1.71],0.5588323640155117
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19485,34,1.38 [0.82-2.33],0.2284940537744488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,18907,83,0.68 [0.41-1.12],0.1309329939801691
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18678,81,0.79 [0.49-1.28],0.3355894212071593
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19392,53,0.70 [0.38-1.30],0.2544113859481354
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,13831,280,1.13 [0.91-1.40],0.2662838125520794
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",15673,2122,1.05 [0.96-1.15],0.2530233842069925
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophagitis,13895,344,1.05 [0.86-1.29],0.6084370858583565
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,14250,699,1.06 [0.92-1.22],0.4433567414179428
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,13623,72,1.19 [0.79-1.79],0.3958521114769465
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13784,233,0.95 [0.73-1.23],0.6905777453651484
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13622,71,0.70 [0.41-1.19],0.1862752134078398
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Gastric ulcer,13713,162,1.33 [1.04-1.70],0.0236646586311691
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,13677,126,1.01 [0.71-1.43],0.9574791649799252
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19345,90,1.05 [0.70-1.56],0.8271207016826155
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Chronic gastritis,13670,119,1.10 [0.79-1.54],0.5811279152806939
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),14359,808,0.99 [0.86-1.14],0.8934099997009729
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of appendix,19370,78,1.05 [0.69-1.61],0.8057315699659251
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,13946,395,1.18 [0.99-1.41],0.0672976635202628
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,13732,181,0.83 [0.61-1.14],0.2620532786775646
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19362,100,1.03 [0.71-1.51],0.8613035567912851
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute appendicitis,19358,66,1.30 [0.88-1.93],0.1902676056592281
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Hernia,16483,1718,0.97 [0.88-1.08],0.6067032211905954
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Inguinal hernia,15438,673,0.84 [0.71-0.99],0.039231910592492
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Umbilical hernia,14872,107,1.24 [0.90-1.71],0.1818836406128814
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ventral hernia,14854,89,0.96 [0.64-1.45],0.8444818453723297
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,15692,927,1.05 [0.93-1.19],0.4157120428480304
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18592,642,1.18 [1.02-1.36],0.0221386048844369
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,14351,1924,1.14 [1.04-1.25],0.0056443221682787
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19201,38,1.20 [0.69-2.10],0.5107006781759164
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",19440,48,1.21 [0.74-1.98],0.4561431260770027
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn disease,17998,48,1.22 [0.75-2.01],0.4249890761823325
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,17984,34,1.40 [0.83-2.37],0.2112928912236545
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",19370,120,1.09 [0.78-1.52],0.6151791928361572
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,18070,120,1.10 [0.79-1.53],0.5868675087473463
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18061,111,1.12 [0.80-1.58],0.5130675586136488
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18480,530,1.19 [1.02-1.38],0.0293826741821682
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18473,523,1.18 [1.01-1.38],0.034488584888012
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,12534,107,1.29 [0.93-1.79],0.1234987956843738
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal stricture,19002,107,1.24 [0.90-1.71],0.1802216072316184
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12497,70,1.30 [0.87-1.94],0.1977010607634923
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,13158,731,1.01 [0.86-1.17],0.9314032568639988
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12557,130,1.20 [0.88-1.63],0.2506172969837813
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,12696,269,1.16 [0.92-1.45],0.2021794060686216
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Constipation,17773,245,1.12 [0.89-1.41],0.3285325266647846
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19083,75,1.31 [0.91-1.89],0.1518693594014412
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12517,90,1.08 [0.72-1.61],0.7100191866284444
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12470,43,1.07 [0.60-1.93],0.812782116194974
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13226,799,1.16 [1.02-1.33],0.0259531559555412
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,12728,301,1.24 [1.01-1.52],0.0407274323790987
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19071,63,1.34 [0.90-1.97],0.1457446099413932
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of liver,18733,97,1.18 [0.82-1.68],0.3737671312877697
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of liver,18685,49,1.15 [0.69-1.90],0.5917526000967839
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18242,579,0.99 [0.84-1.17],0.9317734793577028
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholelithiasis,18129,466,1.04 [0.87-1.24],0.6875423793263199
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Cholecystitis,17760,97,0.61 [0.38-0.98],0.0397975338204733
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,17704,41,1.15 [0.66-1.99],0.627192201099755
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,17723,60,1.24 [0.81-1.90],0.328046241896053
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),19331,60,1.24 [0.81-1.90],0.3252858195963767
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,18234,275,1.23 [1.01-1.51],0.0430652125582871
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18016,57,1.53 [1.07-2.17],0.0183500183263538
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Coeliac disease,18008,49,1.40 [0.93-2.10],0.1080923084402167
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18004,45,1.53 [1.02-2.29],0.0387773422086925
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18138,179,1.07 [0.81-1.41],0.6435815439180592
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XI Diseases of the digestive system,GI-bleeding,18131,172,1.08 [0.82-1.43],0.573709956472913
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,16421,1356,1.07 [0.96-1.19],0.1990651345146098
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19050,95,0.87 [0.57-1.33],0.5287726193975504
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19140,373,1.14 [0.94-1.37],0.1816720189046095
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,17787,529,1.01 [0.86-1.20],0.8759027490981053
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,18612,322,1.13 [0.92-1.38],0.2367225409099559
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18347,57,0.95 [0.56-1.61],0.8454267604854788
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18521,231,1.23 [0.98-1.53],0.0685523914164601
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19218,77,1.00 [0.65-1.56],0.9932823963289624
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19196,55,1.06 [0.64-1.75],0.8295484278529673
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19187,46,1.00 [0.56-1.77],0.9938089074262092
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19136,61,0.96 [0.58-1.59],0.8822510087671835
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19135,60,0.95 [0.57-1.58],0.8342494413065928
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18810,43,1.25 [0.76-2.05],0.3727983366921316
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19077,310,1.11 [0.90-1.36],0.3387187933190968
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17357,99,1.23 [0.88-1.71],0.2258986232011051
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17343,85,1.00 [0.66-1.52],0.9978188735231422
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17317,59,1.03 [0.63-1.69],0.90584192074491
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17456,198,0.79 [0.58-1.08],0.1336695146182603
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17442,184,0.75 [0.54-1.04],0.0830819739399408
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,12761,3681,1.02 [0.94-1.10],0.646328334256594
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,14117,2290,1.01 [0.93-1.10],0.7860806216203442
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,17325,1099,1.00 [0.88-1.12],0.9377476367624972
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,11976,149,1.07 [0.80-1.45],0.6407047175643444
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,12298,471,1.15 [0.98-1.35],0.0858939423256538
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19049,143,1.09 [0.80-1.48],0.5915936782540623
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19053,131,1.14 [0.84-1.56],0.4078371378607207
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,13168,1341,0.99 [0.89-1.11],0.8686592216224526
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",15311,1341,0.99 [0.88-1.10],0.7966740435712818
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,11906,79,0.99 [0.64-1.53],0.9703958618760185
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",18866,76,0.97 [0.62-1.53],0.9052698975364096
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,12055,228,1.24 [1.00-1.53],0.0513537031969842
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,11923,96,0.67 [0.43-1.07],0.0934044536594068
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,12190,363,0.83 [0.66-1.04],0.1038363218747341
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19298,183,0.78 [0.57-1.08],0.1372628895018877
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,12422,595,1.03 [0.88-1.20],0.7254946816457394
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,12283,456,1.12 [0.94-1.32],0.2041359694064833
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,12945,1118,0.98 [0.87-1.11],0.7377673518489198
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),11909,82,1.05 [0.70-1.58],0.8051724715039081
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12070,243,1.03 [0.81-1.31],0.7869801784737368
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11893,66,0.95 [0.59-1.54],0.8417331450696517
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),11904,77,0.89 [0.56-1.41],0.6175007340336389
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12201,374,0.99 [0.81-1.21],0.9463437254533004
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12162,335,1.06 [0.86-1.30],0.6027079241451511
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,14729,233,0.86 [0.65-1.13],0.2699532301754933
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18868,98,1.09 [0.75-1.58],0.6541696248721742
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,18830,60,1.29 [0.85-1.95],0.2270195023949781
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16217,63,1.00 [0.62-1.62],0.9847946367178094
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,16464,310,0.85 [0.67-1.08],0.196768930279357
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,16935,781,0.92 [0.79-1.07],0.273987847222744
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,16353,199,0.87 [0.65-1.17],0.3560042554754423
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16248,94,0.62 [0.39-1.00],0.0509300858731371
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",16734,580,0.92 [0.77-1.09],0.3261933455235943
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16192,38,1.19 [0.68-2.06],0.5426268961041945
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16331,177,1.01 [0.76-1.35],0.9228430660980012
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16226,72,1.04 [0.66-1.63],0.8631227639631808
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16226,72,0.93 [0.58-1.49],0.7518441750192308
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16261,107,1.04 [0.72-1.49],0.846090719181811
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16204,50,1.24 [0.77-2.00],0.3731417588057624
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16389,235,0.83 [0.63-1.10],0.194848340946272
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16506,280,0.93 [0.73-1.19],0.583175032075979
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16293,67,0.47 [0.26-0.86],0.0139004686879913
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16331,105,0.99 [0.68-1.46],0.9746304621504216
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16294,68,1.40 [0.97-2.02],0.0723286007967127
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16262,36,1.38 [0.82-2.31],0.227904692066225
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16368,142,1.13 [0.83-1.53],0.4349019762781888
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16360,134,1.09 [0.80-1.51],0.580631027509288
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16478,252,1.00 [0.78-1.28],0.9866303909301296
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16276,50,1.16 [0.70-1.92],0.5630651212534951
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16311,85,0.76 [0.47-1.22],0.2520377799300302
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16343,117,0.96 [0.66-1.39],0.8317840067227666
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16269,43,0.96 [0.53-1.76],0.9006328982071993
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",16609,383,0.91 [0.74-1.12],0.374758853976921
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16385,159,0.88 [0.63-1.23],0.465820031735366
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16442,216,0.90 [0.68-1.19],0.4720145026648022
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,17516,206,1.08 [0.83-1.39],0.5793720713272035
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,17667,357,0.98 [0.79-1.21],0.841490601213446
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17340,30,0.85 [0.40-1.83],0.6830779550579145
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17346,36,0.76 [0.37-1.57],0.4597223951788283
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17374,64,0.81 [0.48-1.39],0.4495608755712913
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,14340,3380,1.07 [1.00-1.16],0.0643019172731255
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,7489,705,1.09 [0.94-1.27],0.2621431200686485
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,16588,208,1.17 [0.92-1.49],0.1907615911610473
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16443,63,0.95 [0.58-1.57],0.8480001375648774
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,16668,45,1.17 [0.70-1.94],0.5504298334322681
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,16676,53,1.69 [1.21-2.36],0.0021686375462459
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16681,58,1.39 [0.94-2.04],0.0980362730696574
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19171,196,0.87 [0.65-1.18],0.3759200623727585
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19012,65,1.13 [0.73-1.76],0.5758703817299781
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19122,147,0.86 [0.61-1.22],0.3940865078922664
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19032,57,0.85 [0.49-1.48],0.5726249839380305
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,17104,998,1.04 [0.92-1.18],0.5046595046567806
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Cystitis,16188,82,1.07 [0.71-1.60],0.751923456431501
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16183,77,0.89 [0.55-1.42],0.6102785432101443
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,16401,295,1.25 [1.04-1.52],0.020366350686877
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16214,108,1.16 [0.83-1.62],0.3948652719608155
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,16732,626,0.97 [0.83-1.14],0.7094981781519948
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,7194,410,1.08 [0.89-1.31],0.4280099492818366
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6838,54,1.42 [0.93-2.17],0.1081336222358967
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Hydrocele,6834,50,1.23 [0.76-1.99],0.3976382032988927
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6844,60,0.99 [0.60-1.65],0.9740563588929914
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6861,77,1.47 [1.05-2.05],0.0240152052718061
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6870,86,0.71 [0.44-1.17],0.181230511353046
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10134,199,0.91 [0.68-1.22],0.5457725652942921
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,9998,63,1.11 [0.70-1.75],0.6560017477594107
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,10004,69,0.64 [0.36-1.11],0.1107544804618852
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,9990,55,1.15 [0.71-1.87],0.5666575807666353
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10098,147,0.94 [0.67-1.31],0.6967165690257937
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,9997,46,1.05 [0.61-1.83],0.8557434232474257
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,9997,46,1.00 [0.56-1.78],0.9948572177765804
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,9368,1542,1.04 [0.94-1.16],0.4498736992022368
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,7878,52,0.53 [0.27-1.03],0.0624520495631122
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7868,42,0.71 [0.35-1.43],0.3369064737332192
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8237,411,1.07 [0.89-1.30],0.4700999596517532
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7905,79,0.60 [0.35-1.03],0.0623085242272029
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8228,402,1.20 [1.00-1.44],0.0461371280639598
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7951,125,1.24 [0.91-1.69],0.1729658580054023
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8016,190,1.04 [0.78-1.38],0.7855346400389216
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,7840,14,1.44 [0.64-3.22],0.3786948286331011
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,7866,40,1.30 [0.76-2.22],0.3406585864334431
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",10227,54,1.09 [0.65-1.81],0.7440467053269912
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,10229,49,1.18 [0.71-1.96],0.5230027702764355
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,10234,23,1.49 [0.80-2.77],0.2067992760721363
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",10232,27,1.25 [0.64-2.41],0.5111624351695203
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7890,64,0.74 [0.42-1.29],0.2836148306403037
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7873,47,1.41 [0.91-2.20],0.1260842534305963
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7886,60,1.14 [0.71-1.84],0.576048114705239
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,10233,76,1.09 [0.71-1.68],0.6848540030852887
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",7999,173,0.99 [0.72-1.35],0.937881077319669
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,7909,83,0.83 [0.51-1.34],0.4438458258974899
CSPG5,Chondroitin sulfate proteoglycan 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",10235,33,1.13 [0.60-2.13],0.7030872633075478
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7920,94,1.29 [0.92-1.82],0.1422527962653414
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7864,38,1.07 [0.58-1.96],0.8350722677915222
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8381,555,1.05 [0.89-1.24],0.5785525885676525
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19048,70,1.14 [0.74-1.75],0.5495039063736136
CSPG5,Chondroitin sulfate proteoglycan 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,16700,556,0.90 [0.76-1.08],0.252457015431215
